[CLDX] YoY Quarter Result on 30-Jun-2014 [#Q2]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
07-Aug-2014
Financial Year
2014
Quarter
30-Jun-2014 [#Q2]
Profit Trend
QoQ- 5.45%
YoY- -48.69%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Revenue 3,829 1,389 2,178 592 97 2,009 1,952 11.87%
PBT -28,566 -31,952 -32,359 -28,274 -19,016 -13,362 -9,802 19.49%
Tax 1,276 -828 -782 -275 -161 -252 -158 -
NP -28,566 -31,952 -32,359 -28,274 -19,016 -13,773 -10,236 18.63%
Tax Rate - - - - - - - -
Total Cost 32,395 33,341 34,537 28,866 19,113 15,782 12,188 17.67%
Ratio Analysis
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
NP Margin -746.04 -2,300.36 -1,485.72 -4,776.01 -19,604.12 -685.56 -524.39 6.04%
Per Share
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
EPS -3.42 -4.85 -4.93 -4.75 -3.53 -3.52 -4.10 -2.97%
EPS Diluted -3.42 -4.85 -4.93 -4.75 -3.53 -3.52 -4.10 -2.97%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.